Australia markets close in 5 hours 10 minutes

Treace Medical Concepts, Inc. (TMCI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.50+0.03 (+0.32%)
At close: 04:00PM EST
9.50 0.00 (0.00%)
After hours: 04:02PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 585.92M
Enterprise value 534.24M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.23
Price/book (mrq)4.25
Enterprise value/revenue 3.06
Enterprise value/EBITDA -14.06

Trading information

Stock price history

Beta (5Y monthly) 0.06
52-week change 3-60.07%
S&P500 52-week change 315.38%
52-week high 327.97
52-week low 35.27
50-day moving average 39.87
200-day moving average 319.19

Share statistics

Avg vol (3-month) 31.01M
Avg vol (10-day) 31.23M
Shares outstanding 561.68M
Implied shares outstanding 661.68M
Float 844.23M
% held by insiders 128.84%
% held by institutions 164.66%
Shares short (14 Nov 2023) 43.77M
Short ratio (14 Nov 2023) 43.13
Short % of float (14 Nov 2023) 411.01%
Short % of shares outstanding (14 Nov 2023) 46.12%
Shares short (prior month 12 Oct 2023) 42.08M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -27.28%
Operating margin (ttm)-43.72%

Management effectiveness

Return on assets (ttm)-15.14%
Return on equity (ttm)-47.64%

Income statement

Revenue (ttm)174.68M
Revenue per share (ttm)2.94
Quarterly revenue growth (yoy)23.30%
Gross profit (ttm)114.31M
EBITDA -43.79M
Net income avi to common (ttm)-47.66M
Diluted EPS (ttm)-0.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)122.16M
Total cash per share (mrq)1.98
Total debt (mrq)70.49M
Total debt/equity (mrq)51.13%
Current ratio (mrq)5.64
Book value per share (mrq)2.24

Cash flow statement

Operating cash flow (ttm)-40.47M
Levered free cash flow (ttm)-41.96M